when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Immunology · news · pharmadog

← back to Immunology

News · Immunology

412 stories

Jul 14, 26As cyclospora illnesses surge to a record, Michigan officials eye lettuce as a possible causestat

Jul 14, 26Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillbiopharma dive

Jul 14, 26STAT+: Anthropic’s Claude Science is coming for Kendall Squarestat

Jul 14, 26Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces responsestat

Jul 14, 26STAT+: Akero team, backed by Fairmount, launches new immunology companystat

Jul 14, 26Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugsbiopharma dive

Jul 14, 26In latest deal, Innovent seeds Spero's future beyond GSK-owned antibioticendpoints

Jul 14, 26FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientiststat

Jul 13, 26Q32 bounces back to claim study success for alopecia drugbiopharma dive

Jul 13, 26Biotech startup funding gap widens despite rebound in VC investmentbiopharma dive

Jul 10, 26GSK, Hansoh ADC extends survival in lung cancer studybiopharma dive

Jul 9, 26Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfrontendpoints

Jul 8, 26Bryan Johnson’s chronic disease is notoriously difficult to diagnosestat

Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysstat

Jul 8, 26STAT+: Europe will accelerate its review of RevMed’s drugstat

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 7, 26Vera's IgAN approval kicks off competition with Otsukaendpoints

Jul 7, 26STAT+: FDA approves Vera Therapeutics kidney disease treatmentstat

Jul 7, 26Vera Therapeutics wins FDA nod for closely watched kidney disease drugbiopharma dive

Jul 6, 26Cancer, immune drugmakers dominate VC funding so far in 2026biopharma dive

Jul 3, 26Frutas y Hortalizas del Sur S.A. Initiates Recall of Frozen GreenWise Organic IQF Blueberries Due to Potential E. coli O145 Contaminationfda recalls

Jul 2, 26Court halts Colorado price cap on Amgen's blockbuster Enbrelendpoints

Jul 1, 26Kao USA Voluntarily Recalls Some Lots of Oribe Serene Scalp Densifying Shampoofda recalls

Jul 1, 26BridgeBio gets funding for drug launch; United buys into cell therapybiopharma dive

Jul 1, 26Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealbiopharma dive

Jul 1, 26Abivax shares surge as worries subside over immune drug’s cancer riskbiopharma dive

Jul 1, 26STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patientsstat

Jun 30, 26FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patientsfda press

Jun 30, 26Viridian may have edge over Amgen in eye drug showdown, analysts arguebiopharma dive

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

← prevpage 7 of 14next →